
Press releases
6th Sep 2023
UKCA marking achieved for new Genedrive® CYP2C19 test
genedrive Point of Care test that helps manage treatment in stroke patients is now readying for...
16th Jun 2023
genedrive plc (the “Company”), the point of care molecular diagnostics company, today annou...
31st Mar 2023
Interim results to 31 December 2022
genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces unaudited i...